| Industrial Conglomerates Industry | Industrials Sector | Mr. Zhi Qiang Zhang CEO | XSHE Exchange | CNE100001WZ4 ISIN |
| CN Country | 1,550 Employees | 1 Jul 2020 Last Dividend | 8 Sep 2017 Last Split | - IPO Date |
Chongqing Sansheng Industrial Co.,Ltd., a prominent entity in the industrial and pharmaceutical sectors, specializes in the development, production, and sales of building materials and chemicals. Operating on a global scale, the company serves a dual market through two business segments: Buildings Materials Chemical Industry and Pharmaceutical Manufacturing. Founded in 2002 and previously known as Chongqing Sansheng Special Building Materials Co., Ltd., it rebranded to its current name in October 2016. The headquarters of Chongqing Sansheng Industrial Co.,Ltd. is located in Chongqing, China. The company is noted for its diverse product lineup catering to various industries including construction, chemical manufacturing, and healthcare.
Chongqing Sansheng Industrial Co.,Ltd. offers a wide range of building materials designed for multiple sectors such as industrial and civil buildings, highways, railways, bridges, tunnels, airports, water conservancy, and hydropower projects. Their product lineup includes commercial concrete as well as various agents like water reducing and expansion agents that enhance the construction quality and durability of structures.
The company manufactures sulfuric acid primarily used in the production of fertilizers, textiles, steel manufacturing, and other industries. Additionally, it provides concrete admixtures - a critical component for improving concrete performance in construction projects.
Intermediates: These are key components for antibiotic drugs, anti-hepatitis C drugs, diabetes medications, and cosmetics. Chongqing Sansheng's range of intermediates includes procaine hydrochloride, cefoxitin acid intermediates, and more, catering to the production of benzathine penicillin, procaine penicillin, and various other pharmaceutical and cosmetic products.
API (Active Pharmaceutical Ingredients): The company produces essential ingredients like acetaminophen, cloperidine hydrochloride, and levofloxacin mesylate, among others, used in a wide array of drugs for treating various conditions from fever and cough to allergies and bacterial infections.
Preparation Products: Focusing on patient care, Chongqing Sansheng offers numerous preparation products such as compound paracetamol diphenhydramine, cloperidine hydrochloride, and other tablet formulations used in antipyretic, analgesic, anti-inflammatory, antibacterial, cough, allergy, and local anesthesia treatments.
Pharmaceutical Formulations: The company also specializes in the manufacture of solid preparation, large volume infusions, and small volume parenterals, highlighting its comprehensive approach to cover various pharmaceutical needs.